Lista de obras -

A Single Point Mutation (Y89F) within the Non-Structural Protein 1 of Influenza A Viruses Limits Epithelial Cell Tropism and Virulence in Mice

article by Eike R. Hrincius et al published June 2012 in The American Journal of Pathology

A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media

artículo científico publicado en 2014

A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.

artículo científico publicado en 2009

A novel cytotoxic sequence contributes to influenza A viral protein PB1-F2 pathogenicity and predisposition to secondary bacterial infection

scientific article published on 30 October 2013

A practical guide to alcohol-based hand hygiene infrastructure in a resource-poor pediatric hospital.

artículo científico

A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence

artículo científico publicado en 2005

A step closer to meeting the threat of avian influenza

artículo científico publicado en 2006

Acute Lung Injury Results from Innate Sensing of Viruses by an ER Stress Pathway

artículo científico publicado en 2015

Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice

artículo científico publicado en 2013

Advances in vaccine technology and their impact on managed care.

artículo científico publicado en 2008

Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines

artículo científico publicado en 2015

Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice

artículo científico publicado en 2016

Antiviral therapy of influenza.

artículo científico publicado en 2005

Are toilet seats a vector for transmission of methicillin-resistant Staphylococcus aureus?

artículo científico publicado en 2009

Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination

artículo científico publicado en 2015

Association of sputum microbiota profiles with severity of community-acquired pneumonia in children

artículo científico publicado en 2016

Bacterial sinusitis and otitis media following influenza virus infection in ferrets

artículo científico publicado en 2006

Chloroquine is effective against influenza A virus in vitro but not in vivo

scientific article published on September 2007

Chronic helminth infections impair pneumococcal vaccine responses

artículo científico publicado en 2014

Community-Acquired Pneumonia Hospitalization among Children with Neurologic Disorders

artículo científico publicado en 2016

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

artículo científico publicado en 2015

Community-acquired pneumonia requiring hospitalization among U.S. children

artículo científico publicado en 2015

Comparison of immune response to the influenza vaccine in obese and nonobese healthcare workers

artículo científico publicado en 2015

Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications

artículo científico publicado en 2010

Correlates of vaccine protection from influenza and its complications ⬇️

artículo científico publicado el 1 de enero de 2012

Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections

artículo científico publicado en 2013

Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza

artículo científico publicado en 2006

Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?

artículo científico publicado en 2010

Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis

artículo científico publicado en 2006

Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics

artículo científico publicado en 2011

Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza

artículo científico publicado en 2004

Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus

artículo científico publicado en 2017

Evolution, benefits, and shortcomings of vaccine management.

artículo científico publicado en 2007

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia

artículo científico publicado en 2007

Fatal influenza B infections: time to reexamine influenza research priorities

artículo científico publicado en 2012

Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice

artículo científico publicado en 2011

FluBlok, a recombinant influenza vaccine

artículo científico publicado en 2008

Glycan Shielding of the Influenza Virus Hemagglutinin Contributes to Immunopathology in Mice ⬇️

artículo científico publicado el 8 de octubre de 2010

Glycosylation Analysis of Engineered H3N2 Influenza A Virus Hemagglutinins with Sequentially Added Historically Relevant Glycosylation Sites.

artículo científico publicado en 2015

Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence

artículo científico publicado en 2016

Healthcare-Associated Infections at a Children's Cancer Hospital, 1983-2008.

artículo científico publicado en 2012

Helminth infections predispose mice to pneumococcal pneumonia but not to other pneumonic pathogens

artículo científico publicado en 2014

Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia

artículo científico publicado en 2016

Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection

artículo científico publicado en 2016

Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults ⬇️

artículo científico publicado el 9 de diciembre de 2011

Immunopathogenic and Antibacterial Effects of H3N2 Influenza A Virus PB1-F2 Map to Amino Acid Residues 62, 75, 79, and 82 ⬇️

artículo científico publicado el 21 de septiembre de 2011

Immunotherapy with a Combination of Intravenous Immune Globulin and P4 Peptide Rescues Mice from Postinfluenza Pneumococcal Pneumonia ⬇️

artículo científico publicado el 7 de marzo de 2011

Impaired wound healing predisposes obese mice to severe influenza virus infection

artículo científico publicado en 2011

Improving therapeutic strategies for secondary bacterial pneumonia following influenza

artículo científico publicado en 2008

Increased influenza vaccination of healthcare workers at a pediatric cancer hospital: results of a comprehensive influenza vaccination campaign

scientific article published on 06 January 2006

Influence of Antibiotics on the Detection of Bacteria by Culture-Based and Culture-Independent Diagnostic Tests in Patients Hospitalized With Community-Acquired Pneumonia

artículo científico publicado en 2017

Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets.

artículo científico publicado en 2010

Influenza virus neuraminidase contributes to secondary bacterial pneumonia

artículo científico publicado en 2005

Influenza virus primes mice for pneumonia from Staphylococcus aureus.

artículo científico publicado en 2011

Influenza: annual seasonal severity

scientific article published on 01 February 2019

Insights into the interaction between influenza virus and pneumococcus

artículo científico publicado en 2006

Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae

artículo científico publicado en 2013

Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor

artículo científico publicado en 2002

Levels of total fungus and Aspergillus on a pediatric hematopoietic stem cell transplant unit

artículo científico publicado en 2004

Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice

artículo científico publicado en 2014

Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets

artículo científico publicado en 2006

Live attenuated influenza virus increases pneumococcal translocation and persistence within the middle ear.

artículo científico publicado en 2014

Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus

artículo científico publicado en 2008

Low Retinol-Binding Protein and Vitamin D Levels Are Associated with Severe Outcomes in Children Hospitalized with Lower Respiratory Tract Infection and Respiratory Syncytial Virus or Human Metapneumovirus Detection

artículo científico publicado en 2017

Mathematical model of a three-stage innate immune response to a pneumococcal lung infection ⬇️

artículo científico publicado el 12 de febrero de 2011

Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States

artículo científico publicado en 2015

Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses.

artículo científico publicado en 2013

Motivating factors for high rates of influenza vaccination among healthcare workers ⬇️

artículo científico publicado el 23 de junio de 2011

Multiple genotypes of influenza B virus circulated between 1979 and 2003.

artículo científico publicado en 2004

Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia ⬇️

artículo científico publicado en 2019

N-linked glycosylation attenuates H3N2 influenza viruses

artículo científico publicado en 2007

Naturally Occurring Swine Influenza A Virus PB1-F2 Phenotypes That Contribute to Superinfection with Gram-Positive Respiratory Pathogens ⬇️

artículo científico publicado el 6 de junio de 2012

New virulence determinants contribute to the enhanced immune response and reduced virulence of an influenza A virus A/PR8/34 variant

artículo científico publicado en 2013

No evidence of a link between influenza vaccines and Guillain–Barre syndrome–associated antiganglioside antibodies ⬇️

artículo científico publicado el 29 de septiembre de 2011

Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers

artículo científico publicado en 2014

Nonstructural protein 1 (NS1)-mediated inhibition of c-Abl results in acute lung injury and priming for bacterial co-infections: insights into 1918 H1N1 pandemic?

artículo científico publicado en 2014

Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae

artículo científico publicado en 2007

Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia

artículo científico publicado en 2016

PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology

artículo científico publicado en 2010

Planning and implementation of an infection control training program for healthcare providers in Latin America

artículo científico publicado en 2007

Planning for an influenza pandemic: thinking beyond the virus.

artículo científico publicado en 2008

Predicting Severe Pneumonia Outcomes in Children

artículo científico publicado en 2016

Preparing for the next influenza pandemic.

artículo científico publicado en 2008

Preventing and treating secondary bacterial infections with antiviral agents

artículo científico publicado en 2011

Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients

artículo científico publicado en 2014

Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein ⬇️

artículo científico publicado el 16 de agosto de 2011

Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus

artículo científico publicado en 2010

Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia

article published in 2017

Respiratory viruses predisposing to bacterial infections: role of neuraminidase

artículo científico publicado en 2004

Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia

artículo científico publicado en 2017

Risk of catheter-associated infection in young hematology/oncology patients receiving long-term peripheral nerve blocks

artículo científico publicado en 2012

Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae

artículo científico publicado en 2003

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer

artículo científico publicado en 2011

Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia

artículo científico publicado en 2013

Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer ⬇️

artículo científico publicado el 13 de abril de 2011

Secondary bacterial infections in influenza virus infection pathogenesis.

artículo científico publicado en 2014

Secondhand Smoke Exposure and Illness Severity among Children Hospitalized with Pneumonia

artículo científico publicado en 2015

Serology Enhances Molecular Diagnosis of Respiratory Virus Infections Other than Influenza in Children and Adults Hospitalized with Community-Acquired Pneumonia

artículo científico publicado en 2016

Seroprevalence of seasonal and pandemic influenza A viruses in domestic cats ⬇️

artículo científico publicado el 28 de septiembre de 2010

T cell receptor αβ diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection

artículo científico publicado en 2012

The Role of Punctuated Evolution in the Pathogenicity of Influenza Viruses

artículo científico publicado en 2016

The age distribution of mortality due to influenza: pandemic and peri-pandemic

artículo científico publicado en 2012

The clinical need for new antiviral drugs directed against influenza virus

artículo científico publicado en 2006

The co-pathogenesis of influenza viruses with bacteria in the lung.

artículo científico publicado en 2014

The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis

artículo científico publicado en 2010

The immune profile associated with acute allergic asthma accelerates clearance of influenza virus

artículo científico publicado en 2014

The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae

artículo científico publicado en 2005

The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza

artículo científico publicado en 2007

The public health policy implications of understanding metabiosis

artículo científico publicado en 2014

Therapeutics Against Influenza ⬇️

artículo científico publicado el 1 de enero de 2013

Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza

artículo científico publicado en 2009

Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia.

artículo científico publicado en 2018

Use of atmospheric non-thermal plasma as a disinfectant for objects contaminated with methicillin-resistant Staphylococcus aureus

artículo científico publicado en 2009

Vaccines against pandemic influenza: what can be done before the next pandemic?

artículo científico publicado en 2008

Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions

artículo científico publicado en 2014

Virulent PB1-F2 residues: effects on fitness of H1N1 influenza A virus in mice and changes during evolution of human influenza A viruses.

artículo científico publicado en 2018

WASP- mice exhibit defective immune responses to influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG.

artículo científico publicado en 2005

Wild-type and attenuated influenza virus infection of the neonatal rat brain

artículo científico publicado en 2004

c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection.

artículo científico publicado en 2008

El receptor 2 tipo Toll media la inmunopatología fatal en ratones durante el tratamiento de la neumonía neumocócica secundaria después de la gripe ⬇️

artículo científico publicado el 7 de septiembre de 2011

Lista de obras de

A Single Point Mutation (Y89F) within the Non-Structural Protein 1 of Influenza A Viruses Limits Epithelial Cell Tropism and Virulence in Mice

A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media

A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.

A novel cytotoxic sequence contributes to influenza A viral protein PB1-F2 pathogenicity and predisposition to secondary bacterial infection

A practical guide to alcohol-based hand hygiene infrastructure in a resource-poor pediatric hospital.

A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence

A step closer to meeting the threat of avian influenza

Acute Lung Injury Results from Innate Sensing of Viruses by an ER Stress Pathway

Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice

Advances in vaccine technology and their impact on managed care.

Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines

Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice

Antiviral therapy of influenza.

Are toilet seats a vector for transmission of methicillin-resistant Staphylococcus aureus?

Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination

Association of sputum microbiota profiles with severity of community-acquired pneumonia in children

Bacterial sinusitis and otitis media following influenza virus infection in ferrets

Chloroquine is effective against influenza A virus in vitro but not in vivo

Chronic helminth infections impair pneumococcal vaccine responses

Community-Acquired Pneumonia Hospitalization among Children with Neurologic Disorders

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

Community-acquired pneumonia requiring hospitalization among U.S. children

Comparison of immune response to the influenza vaccine in obese and nonobese healthcare workers

Contribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complications

Correlates of vaccine protection from influenza and its complications ⬇️

Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections

Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza

Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?

Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis

Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics

Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza

Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus

Evolution, benefits, and shortcomings of vaccine management.

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia

Fatal influenza B infections: time to reexamine influenza research priorities

Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice

FluBlok, a recombinant influenza vaccine

Glycan Shielding of the Influenza Virus Hemagglutinin Contributes to Immunopathology in Mice ⬇️

Glycosylation Analysis of Engineered H3N2 Influenza A Virus Hemagglutinins with Sequentially Added Historically Relevant Glycosylation Sites.

Glycosylation changes in the globular head of H3N2 influenza hemagglutinin modulate receptor binding without affecting virus virulence

Healthcare-Associated Infections at a Children's Cancer Hospital, 1983-2008.

Helminth infections predispose mice to pneumococcal pneumonia but not to other pneumonic pathogens

Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia

Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection

Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults ⬇️

Immunopathogenic and Antibacterial Effects of H3N2 Influenza A Virus PB1-F2 Map to Amino Acid Residues 62, 75, 79, and 82 ⬇️

Immunotherapy with a Combination of Intravenous Immune Globulin and P4 Peptide Rescues Mice from Postinfluenza Pneumococcal Pneumonia ⬇️

Impaired wound healing predisposes obese mice to severe influenza virus infection

Improving therapeutic strategies for secondary bacterial pneumonia following influenza

Increased influenza vaccination of healthcare workers at a pediatric cancer hospital: results of a comprehensive influenza vaccination campaign

Influence of Antibiotics on the Detection of Bacteria by Culture-Based and Culture-Independent Diagnostic Tests in Patients Hospitalized With Community-Acquired Pneumonia

Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets.

Influenza virus neuraminidase contributes to secondary bacterial pneumonia

Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Influenza: annual seasonal severity

Insights into the interaction between influenza virus and pneumococcus

Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae

Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor

Levels of total fungus and Aspergillus on a pediatric hematopoietic stem cell transplant unit

Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice

Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets

Live attenuated influenza virus increases pneumococcal translocation and persistence within the middle ear.

Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus

Low Retinol-Binding Protein and Vitamin D Levels Are Associated with Severe Outcomes in Children Hospitalized with Lower Respiratory Tract Infection and Respiratory Syncytial Virus or Human Metapneumovirus Detection

Mathematical model of a three-stage innate immune response to a pneumococcal lung infection ⬇️

Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States

Molecular signatures of virulence in the PB1-F2 proteins of H5N1 influenza viruses.

Motivating factors for high rates of influenza vaccination among healthcare workers ⬇️

Multiple genotypes of influenza B virus circulated between 1979 and 2003.

Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia ⬇️

N-linked glycosylation attenuates H3N2 influenza viruses

Naturally Occurring Swine Influenza A Virus PB1-F2 Phenotypes That Contribute to Superinfection with Gram-Positive Respiratory Pathogens ⬇️

New virulence determinants contribute to the enhanced immune response and reduced virulence of an influenza A virus A/PR8/34 variant

No evidence of a link between influenza vaccines and Guillain–Barre syndrome–associated antiganglioside antibodies ⬇️

Non-avian animal reservoirs present a source of influenza A PB1-F2 proteins with novel virulence-enhancing markers

Nonstructural protein 1 (NS1)-mediated inhibition of c-Abl results in acute lung injury and priming for bacterial co-infections: insights into 1918 H1N1 pandemic?

Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae

Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia

PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology